Welcome : Guest

Rising Incidence of Fibromyalgia Syndrome and Anticipated Launch of New Drugs to Spur Growth in the Fibromyalgia Therapeutics Market


Published: April 2017

REPORT STATISTICS


  • Code: MCP-6917
  • Pages: 78
  • Tables: 8
  • Companies: 22


FIBROMYALGIA THERAPEUTICS: A RESEARCH BRIEF

The global Fibromyalgia Therapeutics market is projected to reach US$1.8 billion by 2022, with growth supported by the rise in incidence and diagnosis of fibromyalgia syndrome and the expected launch of new drugs that are currently in research stage. As the new therapies are expected to be launched at premium prices relative to existing therapies in the market, value growth is poised to benefit. The United States represents the largest and the fastest growing market worldwide supported by incidence rates as high as 3-5% of the total population; growing awareness and overall understanding of the disease as a result of high profile awareness campaigns. The large share of the country in the global market is also due to the fact that it is the only country to have approved the three fibromyalgia drug brands, namely Cymbalta, Lyrica and Savella. 

    Summary of Findings

  • The Introduction of Newer, Late-stage Pipeline Therapies to Drive Market Growth
  • Off-label Analgesics, Sedatives, Muscle Relaxants, Neuroleptics and Anti-Depressants Find Use in Fibromyalgia Treatment
  • Development of Fibromyalgia Treatment through High-Pressure Oxygen Application
  • Tonix Pharma Develops Newer Sublingual Formulation of Cyclobenzaprine
  • Europe Approves an Innovative Device with Transcranial Direct Current Stimulation to Treat Fibromyalgia and Migraine Headache

    Timeline for Analysis

  • Market Estimates and Forecasts for 2015-2022
  • Historic Review 2009-2014

    Geographic Markets Analyzed

  • US, Japan, Europe (France, Germany, Italy, UK, Spain and Rest of Europe), and Rest of World

MAJOR PLAYERS

  • Allergan plc
  • Boehringer Ingelheim GmbH
  • Daiichi Sankyo Company Limited
  • Eli Lilly and Company
  • Innovative Med Concepts, Inc.
  • Pfizer, Inc.
  • Pierre Fabre Médicament
  • SWITCHBIOTECH LLC

KEY RESEARCH DELIVERABLES

  • Review of Industry/Market Structure
  • Analysis of Trends & Drivers
  • Insights on Macro Market Scenarios
  • Market SWOT Analysis
  • Latent Demand Forecasts & Projections
  • Comprehensive Geographic Market Analysis
  • Presentation Ready Facts & Statistical Data Findings
  • Coverage of Major/Niche Players, Market Shares & Competition
  • Coverage of major Company/Technology/Product/Financial Stories
  • Extensive Product/Service/End-Use/Technology Coverage Where Applicable

INFOGRAPHICS ON FIBROMYALGIA THERAPEUTICS

1. http://www.mba-healthcare-management.com/fibromyalgia/